Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors
โ Scribed by Matthew R. Smith
- Book ID
- 107550295
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 243 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1544-225X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec
Prostate glands exposed to androgen deprivation with leuprolide -+ flutamide were evaluated for pathologic changes which might be related to therapy. Comparing pretreatment and posttreatment tissue by visual discrimination using light microscopic study revealed treatment-related alterations in the s